NCT06530056

Brief Summary

Aim of this study is to find the effects of Costoverterbral Mobilization on Thoracic kyphosis and Lung function in non-smoker. A randomized control trial that will include total 44 participants.The first group will receive Costovertebral Mobilization along with conventional therapy and 2nd group will receive conventional therapy.Data collected will be analyzed through SPSS 25

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
44

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Aug 2024

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 28, 2024

Completed
3 days until next milestone

First Posted

Study publicly available on registry

July 31, 2024

Completed
8 days until next milestone

Study Start

First participant enrolled

August 8, 2024

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 30, 2024

Completed
11 days until next milestone

Study Completion

Last participant's last visit for all outcomes

January 10, 2025

Completed
Last Updated

August 14, 2024

Status Verified

August 1, 2024

Enrollment Period

5 months

First QC Date

July 28, 2024

Last Update Submit

August 13, 2024

Conditions

Keywords

HyperkyphosisPulmonary FunctionsCostoverterbral MobilizationFEV1/FVCCobb Angle

Outcome Measures

Primary Outcomes (1)

  • X-RAY

    X-ray is a gold standard method for objective assessment of Thoracic Kyphosis.

    3 weeks

Secondary Outcomes (1)

  • Spirometer

    3 weeks

Study Arms (2)

Costovertebral Mobilization+Conventional Therapy

EXPERIMENTAL

Costovertebral mobilization: It will be performed in 3 Different Positions to target specific regions of rib cage. Conventional Therapy: Hot pack 10 mints, Posture corrective exercises, Breathing exercises.

Other: Costovertebral Mobilization+Conventional Therapy

Conventional Therapy

OTHER

Conventional Therapy: Hot pack 10 mints, Posture corrective exercises, Breathing exercises

Other: Conventional Therapy

Interventions

Patient would receive costovertebral mobilization in side lying position for left 10th to 6th, in sitting position for right 10th to 2nd rib and in supine lying position for 1st rib. Conventional Therapy: Hot pack 10 mints, Posture corrective exercises, Breathing exercises Frequency; 4 times/week for 3 weeks

Costovertebral Mobilization+Conventional Therapy

Electrotherapy: • Hot Pack 10 minutes Posture Corrective Exercises: * Thoracic Rotation 10 rep/session * Thoracic extension 10 rep/session * Scapular retraction 5 rep/session * Deep neck flexor Isometric 5 rep/session Deep Breathing Exercises: • Pursed lip breathing 10 repetition in one session

Conventional Therapy

Eligibility Criteria

Age20 Years - 40 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Non smoker
  • Age: 20-40 years
  • Normal Body Mass Index 18.5 To 24.9
  • Both female and male gender
  • Decrease forced expiratory volume-one second/ forced vital capacity ratio greater than or equal to 70%
  • Increase Thoracic kyphotic posture greater than or equal to 40˚

You may not qualify if:

  • Any respiratory disease of the upper or lower respiratory tracts e.g. asthma, chronic bronchitis, COPD, emphysema etc. which could altered the optimal lung functioning.
  • Previous history of rib fractures, dislocations, sprains of costochondral, costosternal and interchondral joints.
  • Smokers
  • Scheuermann Disease
  • Primary and Secondary neoplastic lesions of the spine and/or ribs
  • Obvious advanced spinal deformity e.g. kyphoscoliosis
  • Infection e.g. tuberculosis
  • Primary and secondary neoplastic lesions of the soft tissue structures of the chest
  • Inflammation e.g. acute rheumatoid arthritis or ankylosing spondylitis

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Madiha Ali

Islamabad, 44000, Pakistan

RECRUITING

MeSH Terms

Conditions

Kyphosis

Condition Hierarchy (Ancestors)

Spinal CurvaturesSpinal DiseasesBone DiseasesMusculoskeletal Diseases

Study Officials

  • Madiha Ali, MSOMPT

    Riphah International University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Madiha Ali, MSOMPT

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 28, 2024

First Posted

July 31, 2024

Study Start

August 8, 2024

Primary Completion

December 30, 2024

Study Completion

January 10, 2025

Last Updated

August 14, 2024

Record last verified: 2024-08

Data Sharing

IPD Sharing
Will not share

Locations